It has been nearly eight years since Sen. John McCain’s middle-of-the-night thumbs-down vote torpedoed Republican efforts to repeal the Affordable Care Act and make drastic cuts to Medicaid. With Donald Trump back in the White House and the GOP back in control of Congress, Republicans again have their eyes on Medicaid, the government health program…
This starts with viewing specialties such as oral health, maternal health, endocrinology, and cardiology — among others — as interconnected practices, not as separate areas. It also requires combining education, innovation, and investment to truly see — and feel — positive change and interconnected care The post Our Next Generations’ Health Depends on the Oral…
KFF Health News editor-at-large for public health Céline Gounder discussed bird flu on CBS’ “CBS Mornings Plus” on March 20. Gounder discussed funding cuts at Johns Hopkins University and other research institutions on CBS News’ “CBS Morning News” on March 17. She also discussed the Centers for Disease Control and Prevention’s airplane wastewater testing to…
With $50 million commitment, public-benefit company to partner with the Purchaser Business Group on Health and the National Alliance of Healthcare Purchaser Coalitions
The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs. The antibody offers the potential to prevent blood clots without the bleeding risks associated with currently available anticoagulants. The post Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots appeared first on MedCity News.
A new report from the Peterson Health Technology Institute argues that today’s healthcare payment models are ill-suited for clinical AI and could drive up costs. The post How Should Clinical AI Be Paid For? 3 Takeaways appeared first on MedCity News.
Merck’s Lipfendra is the first FDA-approved pill in the class of cholesterol-lowering drugs called PCSK9 inhibitors. While peptides are typically injected, Lipfendra is a macrocyclic peptide designed for formulation as an oral drug. The post Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs appeared first on MedCity News.
This policy watch evaluates state awards through the rural health fund in 2026, the first year of the program. The analysis shows relatively modest variations in total awards this year across states but wide variation in how much states will receive per rural resident.
Outpatient facilities and microhospitals improve care access, but as patients receive care across more places, data becomes more fragmented, requiring an adapted approach to non-interventional research The post Bridging Healthcare’s Data Gaps as Care Expands Beyond Traditional Settings appeared first on MedCity News.
[Sponsored] A webinar, sponsored by Verato, offered a robust discussion with executives from Providence, Yale New Haven Health System and Verato on navigating an increasingly complex landscape of sharing electronic patient data. The post Preventing Medical Errors in Patient Identity Through Data Matching, VBC, and Interoperability Standards appeared first on MedCity News.